ANGPTL2 is known to promote cell proliferation, metastasis, and EMT in lung cancer, breast cancer, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma [38–41]. Here, ANGPTL2 is linked to breast carcinoma.